Politics

Some research advocates fear the Advanced Research Projects Agency for Health could be left behind in a crush of end-of-session business and lose momentum.

In his latest press conference, he implied their policies are linked to donations from big pharmaceutical firms.

The New Jersey Democrat refuses to say whether his resistance to Medicare drug bargaining will turn him against the reconciliation bill.

Negotiating Medicare drug prices is a linchpin of President Joe Biden's ambitious health care agenda.

With Democrats in Washington debating the specifics of the president's infrastructure program, the pharmaceutical industry may be able to squeak out a much-desired drug pricing win.

The vast majority of the American people want us to substantially lower prescription drug costs.

It is a crucial day of negotiations on both sides of Pennsylvania Avenue in Washington, D.C., where Democrats are working around the clock to pass 2 significant bills — on infrastructure and major Democratic priorities in a reconciliation bill.

As Democratic leaders try to establish a politically feasible path forward for the $3.5 trillion budget reconciliation bill, they appear to be caving in to the demands of a small, but influential group of House and Senate centrists.

Despite the feverish negotiations and the stakes involved, more than half of Americans are not closely watching the debate in Congress, according to the poll.

The proposals in flux range from tinkering with tax credits to far-reaching changes in federal payments systems.

"Opposing these policies doesn't make you a moderate," said Warren Gunnels. "It doesn't make you a centrist. It makes you an extremist."

A new poll found that 56% of voters support giving Medicare the power to negotiate for lower drug prices for certain products, but only 50% want it to be included in a major infrastructure package.

It’s a sign the drug industry is bending a potential compromise in manufacturers’ favor after spending more than $171 million lobbying in the first half of this year.

While the votes were not unanimous, they passed the committee by a big margin. A fourth measure is set to be considered on Thursday.

56% of voters support allowing the federal government to negotiate some prescription drug prices in general.